Intercell Completes Equity Private Placement

Business › n.a. ♦ Published: May 15, 2012; 14:28 ♦ (Vindobona)

The Austrian pharmaceutical company raises funds of € 15.2m at a price of € 2.30 per new share - bringing total volume of combined debt and equity financing to € 35.2m.

Intercell Completes Equity Private Placement / Picture: © Vindobona.org

Intercell AG today announced that it successfully completed a previously announced financing transaction consisting of a € 20.0m secured loan (the "Term Loan") provided by BB Biotech and an equity private placement (the "Private Placement") of approximately € 15.2m. The Intercell shares were placed at an adjusted price of € 2.30, corresponding to the opening share price of…

or Log In

Fast News Search
Related News
Intercell Remains in the Loss Area (May 8, 2012)
Intercell Does Not Leave the Loss zone (March 6, 2012)
Intercell Plans to Achieve Turnaround in 2014 (February 6, 2012)
New Chairman for Intercell’s Supervisory Board (December 30, 2011)
Intercell Receives Approval for Vaccine in India (November 10, 2011)
Read More
Intercell, Capital Markets, Equity Markets, Pharmaceutical Industry
Featured
See latest Vindobona Newsletter